1. Home
  2. XNCR vs TBLD Comparison

XNCR vs TBLD Comparison

Compare XNCR & TBLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XNCR
  • TBLD
  • Stock Information
  • Founded
  • XNCR 1997
  • TBLD 2021
  • Country
  • XNCR United States
  • TBLD United States
  • Employees
  • XNCR N/A
  • TBLD N/A
  • Industry
  • XNCR Biotechnology: Pharmaceutical Preparations
  • TBLD Investment Managers
  • Sector
  • XNCR Health Care
  • TBLD Finance
  • Exchange
  • XNCR Nasdaq
  • TBLD Nasdaq
  • Market Cap
  • XNCR 565.1M
  • TBLD 543.1M
  • IPO Year
  • XNCR 2013
  • TBLD N/A
  • Fundamental
  • Price
  • XNCR $8.44
  • TBLD $19.59
  • Analyst Decision
  • XNCR Buy
  • TBLD
  • Analyst Count
  • XNCR 7
  • TBLD 0
  • Target Price
  • XNCR $27.50
  • TBLD N/A
  • AVG Volume (30 Days)
  • XNCR 777.2K
  • TBLD 78.5K
  • Earning Date
  • XNCR 08-04-2025
  • TBLD 01-01-0001
  • Dividend Yield
  • XNCR N/A
  • TBLD 6.39%
  • EPS Growth
  • XNCR N/A
  • TBLD N/A
  • EPS
  • XNCR N/A
  • TBLD N/A
  • Revenue
  • XNCR $127,228,000.00
  • TBLD N/A
  • Revenue This Year
  • XNCR N/A
  • TBLD N/A
  • Revenue Next Year
  • XNCR $28.84
  • TBLD N/A
  • P/E Ratio
  • XNCR N/A
  • TBLD N/A
  • Revenue Growth
  • XNCR N/A
  • TBLD N/A
  • 52 Week Low
  • XNCR $7.16
  • TBLD $15.80
  • 52 Week High
  • XNCR $27.24
  • TBLD $19.97
  • Technical
  • Relative Strength Index (RSI)
  • XNCR 47.36
  • TBLD 58.93
  • Support Level
  • XNCR $7.93
  • TBLD $18.77
  • Resistance Level
  • XNCR $9.48
  • TBLD $19.80
  • Average True Range (ATR)
  • XNCR 0.53
  • TBLD 0.42
  • MACD
  • XNCR 0.06
  • TBLD -0.03
  • Stochastic Oscillator
  • XNCR 43.29
  • TBLD 68.33

About XNCR Xencor Inc.

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.

About TBLD Thornburg Income Builder Opportunities Trust

Thornburg Income Builder Opportunities Trust is a diversified, closed-end management investment company. The Trust's investment objective is to provide current income. The Trust will seek to achieve its investment objective by investing, directly or indirectly, at least 80% of its Managed Assets.

Share on Social Networks: